Medical Experts Rebut Trump’s Claims Linking Tylenol to Autism

During the press conference, Trump urged the public to avoid the common fever reducer, claiming it creates a link to neurodevelopmental disorders. The statement drew an immediate rebuke from the American College of Obstetricians and Gynecologists, which affirmed that two decades of research have failed to establish any causal connection between the drug and autism. Experts emphasized that untreated fevers during pregnancy pose greater health risks to both parent and fetus than the controlled use of the medication.

Helen Tager-Flusberg, founder of the Coalition of Autism Scientists, described the event as an unhinged discussion that ignored established evidence. Beyond the Tylenol claims, the administration repeated debunked theories regarding vaccines and autism. Critics, including British Health Secretary Wes Streeting, urged the public to disregard the president’s medical advice, noting that his assertions were not supported by clinical data. Meanwhile, researchers highlighted that the rising number of autism diagnoses reflects improved awareness and diagnostic criteria, rather than a public health crisis requiring the stigmatization of neurodivergent individuals.